236 related articles for article (PubMed ID: 20425414)
21. Somatic mutations in
Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
[TBL] [Abstract][Full Text] [Related]
22. Aggressive natural killer cell leukaemia: a rare and fatal disorder.
Gogia A; Kakar A; Byotra SP; Bhargav M
J Assoc Physicians India; 2010 Nov; 58():702-4. PubMed ID: 21510468
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cell neoplasm: biology and pathology.
Ham MF; Ko YH
Int J Hematol; 2010 Dec; 92(5):681-9. PubMed ID: 21132576
[TBL] [Abstract][Full Text] [Related]
24. NK-cell neoplasms in Japan.
Oshimi K; Kawa K; Nakamura S; Suzuki R; Suzumiya J; Yamaguchi M; Kameoka J; Tagawa S; Imamura N; Ohshima K; Kojya S; Iwatsuki K; Tokura Y; Sato E; Sugimori H;
Hematology; 2005 Jun; 10(3):237-45. PubMed ID: 16019472
[TBL] [Abstract][Full Text] [Related]
25. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
26. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder.
Huang Q; Chang KL; Gaal KK; Weiss LM
Am J Surg Pathol; 2005 Nov; 29(11):1540-3. PubMed ID: 16224224
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
28. T cell and NK cell lymphoproliferative disorders.
Greer JP; Kinney MC; Loughran TP
Hematology Am Soc Hematol Educ Program; 2001; ():259-81. PubMed ID: 11722988
[TBL] [Abstract][Full Text] [Related]
29. Hematopoietic stem cell transplantation in natural killer cell lymphoma and leukemia.
Kwong YL
Int J Hematol; 2010 Dec; 92(5):702-7. PubMed ID: 21107769
[TBL] [Abstract][Full Text] [Related]
30. Classification of cytotoxic T-cell and natural killer cell lymphomas.
Jaffe ES; Krenacs L; Raffeld M
Semin Hematol; 2003 Jul; 40(3):175-84. PubMed ID: 12876666
[TBL] [Abstract][Full Text] [Related]
31. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
32. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.
Kohrt H; Advani R
Leuk Lymphoma; 2009 Nov; 50(11):1773-84. PubMed ID: 19883307
[TBL] [Abstract][Full Text] [Related]
33. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting.
Cohen JI; Iwatsuki K; Ko YH; Kimura H; Manoli I; Ohshima K; Pittaluga S; Quintanilla-Martinez L; Jaffe ES
Leuk Lymphoma; 2020 Apr; 61(4):808-819. PubMed ID: 31833428
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms.
Sekiguchi N; Asano N; Ito T; Momose K; Momose M; Ishida F
Int J Hematol; 2012 Oct; 96(4):461-8. PubMed ID: 22890551
[TBL] [Abstract][Full Text] [Related]
36. Natural killer-cell malignancies: diagnosis and treatment.
Kwong YL
Leukemia; 2005 Dec; 19(12):2186-94. PubMed ID: 16179910
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
38. T-cell and NK-cell posttransplantation lymphoproliferative disorders.
Swerdlow SH
Am J Clin Pathol; 2007 Jun; 127(6):887-95. PubMed ID: 17509986
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma.
Cai Q; Cai J; Fang Y; Young KH
Front Oncol; 2019; 9():386. PubMed ID: 31139570
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cell malignancies: clinicopathologic and molecular features.
Siu LL; Chan JK; Kwong YL
Histol Histopathol; 2002 Apr; 17(2):539-54. PubMed ID: 11962758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
